References
- . Anderson, E. L., Gramling, P. K., Vestal, P. R. & Farrar, W. E.: Susceptibility of Pseudomonas aeruginosa to tobramycin or gentamicin alone and combined with carbenicillin. Antimicrob Agents Chemother 8: 300, 1975.
- . Davies, J. & Kass, E. H.: Bacterial resistance to aminoglycoside antibiotics. J Infect Dis 124, Suppl.: S7, 1971.
- . Gibson, L. E. & Cooke, R. E.: A test for concentration of electrolytes in sweat in cystic fibrosis of the pancreas utilizing pilocarpin by iontophoresis. Pediatrics 48: 545, 1959.
- . Hawley, H. B., Lewis, R. M., Swartz, D. R. & Gump, D. W.: Tobramycin therapy of pulmonary infections in patients with cystic fibrosis. Curr Ther Res 16: 414, 1974.
- . Hoff, G. E., Schiøtz, P. O. & Paulsen, J.: Tobramycin treatment of Pseudomonas aeruginosa infections in cystic fibrosis. Scand J Infect Dis 6: 333, 1974.
- . Huang, N. N., Hiller, E. J., Macri, C. M., Capitanio, M. & Cundy, K. R.: Carbenicillin in patients with cystic fibrosis: Clinical pharmacology and therapeutic evaluation. J Pediatr 78: 338, 1971.
- . Høiby, N. & Axelsen, N. H.: Identification and quantitation of precipitins against Pseudomonas aeruginosa in patients with cystic fibrosis by means of crossed immunoelectrophoresis with intermediate gel. Acta Pathol Microbiol Scand (B) 81: 298, 1973.
- . Høiby, N.: Epidemiological investigations of the respiratory tract. Bacteriology in patients with cystic fibrosis. Acta Pathol Microbiol Scand (B) 82: 541, 1974.
- . Høiby, N.: Pseudomonas aeruginosa infection in cystic fibrosis. Relationship between mucoid strains of Pseudomonas aeruginosa and the humoral immune response. Acta Pathol Microbiol Scand (B) 82: 551, 1974.
- . Høiby, N., Flensborg, E. W., Beck, B., Friis, B., Jacobsen, S. V. & Jacobsen, L.: Pseudomonas aeruginosa infection in cystic fibrosis. Diagnostic and prognostic significance of Pseudomonas aeruginosa. Precipitins determined by means of crossed immunoelectrophoresis. Scand J Respir Dis 58: 65, 1977.
- . Klastersky, J., Henri, A. & Vandenborre, L.: Antimicrobial activity of tobramycin and gentamicin used in combination with cephalothin and carbenicillin. Am J Med Sci 226: 13, 1973.
- . Kluge, R. M., Standiford, H. C., Tatem, B., Young, V. M., Schimpff, S. C., Greene, W. H., Calia, F. M. & Hornick, R. B.: The carbenicillin-gentamicin combination against Pseudomonas aeruginosa. Correlation of effect with gentamicin sensitivity. Ann Intern Med 81: 584, 1974.
- . Kluge, R. M., Standiford, H. C., Tatem, B., Young, V. M., Greene, W. H., Schimpff, S. C., Calia, F. M. & Hornick, R. B.: Comparative activity of tobramycin, amikacin, and gentamicin alone and with carbenicillin against Pseudomonas aeruginosa. Antimicrob Agents Chemother 6: 442, 1974.
- . Marks, M. I., Prentice, R., Swarson, R., Cotton, E. K. & Eickhoff, T. C.: Carbenicillin and gentamicin: Pharmacologic studies in patients with cystic fibrosis and pseudomonas pulmonary infections. J Pediatr 79: 822, 1971.
- . McCrae, W. M.: Treatment of pseudomonas infection in cystic fibrosis using tobramycin. Scott Med J 21: 68, 1976.
- . Meyer, R. D., Young, L. S. & Armstrong, D.: Tobramycin (Nebramycin factor 6): In vitro activity against Pseudomonas aeruginosa. Appl Microbiol 22: 1147, 1971.
- . Meyers, B. R. & Hirschman, S. Z.: Pharmacologic studies on tobramycin and comparison with gentamicin. J Clin Pharmacol 12: 321, 1972.
- . Møller, N. E.: Side effects of carbenicillin treatment of patients with cystic fibrosis and chronical infections with Pseudomonas aeruginosa. Ugeskr Læger. In press.
- . Thomsen, J., Friis, B., Jensen, K., Pedersen, K. B. & Larsen, P. K.: Tobramycin ototoxicity by high dosage treatment of children with cystic fibrosis. A minimal clinical risk. J Antimicrob Chemother. In press.